Skip to main content
Premium Trial:

Request an Annual Quote

GeneDx, Krystal Biotech Partner to Offer Free Genetic Testing for Rare Skin Disease

NEW YORK — GeneDx has partnered with gene therapy developer Krystal Biotech to provide no-cost genetic testing for epidermolysis bullosa, a rare skin disorder for which Krystal is developing a treatment, the companies said on Tuesday.

EB is characterized by fragile skin that is prone to blistering and tearing. There are four types of the disease, each caused by mutations in different genes. Krystal currently has a drug for dystrophic EB, which is caused by mutations in the COL7A1 gene, in Phase III development.

Under the terms of their deal, Krystal and GeneDx will work together to provide free genetic testing for all forms of EB, with the goal of helping dystrophic EB patients receive a diagnosis sooner. The test, the companies said, uses a panel of genes to distinguish different forms of EB, as well as genetic conditions with similar symptoms.

Additional terms were not disclosed.

"Many suspected EB patients do not receive diagnostic testing due to lack of insurance coverage, cost of assessment, and unfamiliarity with the impact of genetic information on healthcare delivery," Jeanett Segal, US medical director for Krystal, said in a statement. "Fortunately, genetic tests are available, and we are thrilled to work with GeneDx to offer this at no charge to patients with EB symptoms."

Gaithersburg, Maryland-based GeneDx is a subsidiary of Opko Health's BioReference Laboratories.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.